Market Cap | 3.09M | P/E | 0.03 | EPS this Y | 111.60% | Ern Qtrly Grth | - |
Income | -14.46M | Forward P/E | -0.25 | EPS next Y | 41.00% | 50D Avg Chg | -14.00% |
Sales | 19.59M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -69.00% |
Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -93.00% |
Recommedations | 3.00 | Quick Ratio | 0.29 | Shares Outstanding | 6.86M | 52W Low Chg | 13.00% |
Insider Own | 0.42% | ROA | -101.46% | Shares Float | 6.85M | Beta | 1.40 |
Inst Own | 3.71% | ROE | - | Shares Shorted/Prior | 222.10K/189.89K | Price | 2.74 |
Gross Margin | 54.18% | Profit Margin | -73.83% | Avg. Volume | 118,146 | Target Price | 5.00 |
Oper. Margin | -112.12% | Earnings Date | May 9 | Volume | 28,568 | Change | -6.48% |
Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. The company was incorporated in 1997 and is headquartered in Princeton, New Jersey.
Maxim Group | Hold | Mar 18, 24 |
Maxim Group | Buy | Sep 22, 23 |
HC Wainwright & Co. | Buy | Jun 26, 23 |
HC Wainwright & Co. | Buy | Jun 7, 23 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
ALTOMARI ALFRED | Chief Executive Offi.. Chief Executive Officer | Aug 26 | Buy | 0.45 | 50,000 | 22,500 | 64,343 | 08/29/22 |